Live Breaking News & Updates on Mario Lacouture|Page 3
Stay updated with breaking news from Mario lacouture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novel BRAF-Inhibitor Cream Ameliorates Rash From EGFR Inhibitors medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
FTSE 100 holds on to gains and shrugs off mixed performance from Wall Street proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
FTSE 100 holds on to gains and shrugs off mixed performance from Wall Street proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: PyroGenesis Canada Inc, Energy Fuels Inc, Biocept Inc, EVmo Inc, BetterLife Pharma Inc, District Metals Corp, Cloud Nine Education Group Ltd UPDATE ... proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article SAN DIEGO, March 3, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the appointment of Mario Lacouture, M.D. to the REM-001 Scientific Advisory Board with the initial focus in Cutaneous Metastatic Breast Cancer (CMBC). We are pleased to welcome Dr. Lacouture to our CMBC focused Scientific Advisory Board as we prepare REM-001, our photodynamic therapy platform, for late-stage pivotal testing in this debilitating oncology indication, commented Saiid Zarrabian, Kintara s Chief Executive Officer. We look forward to working closely with Dr. Lacouture, utilizing his experience as a leading expert in the treatment of CMBC to ensure REM-001 s pivotal clinical trial is optimally designed and executed. ....